BARBARO, MARIA RAFFAELLA
 Distribuzione geografica
Continente #
NA - Nord America 4.524
AS - Asia 3.481
EU - Europa 3.222
AF - Africa 297
SA - Sud America 215
Continente sconosciuto - Info sul continente non disponibili 207
OC - Oceania 21
Totale 11.967
Nazione #
US - Stati Uniti d'America 4.395
IT - Italia 1.722
SG - Singapore 919
CN - Cina 846
VN - Vietnam 767
GB - Regno Unito 345
HK - Hong Kong 323
SE - Svezia 201
DE - Germania 197
IN - India 161
BR - Brasile 146
FR - Francia 142
NL - Olanda 125
RU - Federazione Russa 105
KR - Corea 103
BD - Bangladesh 98
IE - Irlanda 77
CI - Costa d'Avorio 72
TG - Togo 72
CA - Canada 67
FI - Finlandia 60
JP - Giappone 59
ZA - Sudafrica 57
CH - Svizzera 40
BE - Belgio 29
AR - Argentina 27
CD - Congo 27
NG - Nigeria 26
PH - Filippine 26
TH - Thailandia 26
EE - Estonia 25
ID - Indonesia 25
UA - Ucraina 24
AT - Austria 23
JO - Giordania 20
SC - Seychelles 20
BG - Bulgaria 19
ES - Italia 18
AU - Australia 17
EC - Ecuador 17
TR - Turchia 17
MX - Messico 15
CO - Colombia 13
IR - Iran 13
PL - Polonia 13
TW - Taiwan 13
AL - Albania 10
PT - Portogallo 10
JM - Giamaica 9
IQ - Iraq 7
MY - Malesia 7
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
EG - Egitto 6
HN - Honduras 6
CZ - Repubblica Ceca 5
HR - Croazia 5
KZ - Kazakistan 5
NI - Nicaragua 5
AZ - Azerbaigian 4
CL - Cile 4
CR - Costa Rica 4
DK - Danimarca 4
LT - Lituania 4
MA - Marocco 4
NP - Nepal 4
NZ - Nuova Zelanda 4
SA - Arabia Saudita 4
SM - San Marino 4
TT - Trinidad e Tobago 4
UZ - Uzbekistan 4
GD - Grenada 3
IL - Israele 3
KE - Kenya 3
KG - Kirghizistan 3
LV - Lettonia 3
NO - Norvegia 3
PY - Paraguay 3
YE - Yemen 3
AG - Antigua e Barbuda 2
BB - Barbados 2
BY - Bielorussia 2
BZ - Belize 2
GR - Grecia 2
OM - Oman 2
RO - Romania 2
SV - El Salvador 2
TN - Tunisia 2
UY - Uruguay 2
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
Totale 11.743
Città #
Singapore 672
Ashburn 427
Bologna 293
Hong Kong 291
San Jose 270
Fairfield 249
Southend 241
Hefei 208
Ho Chi Minh City 203
Hanoi 173
Milan 171
Santa Clara 158
Chandler 136
Woodbridge 126
Seattle 122
Houston 115
Los Angeles 114
Wilmington 112
Council Bluffs 111
Rome 110
New York 105
Seoul 95
Beijing 93
Cambridge 92
Boardman 89
Princeton 81
Dallas 77
Dublin 75
Brescia 74
Abidjan 72
Lomé 72
Ann Arbor 69
Florence 57
Dong Ket 54
Lauterbourg 49
Tokyo 48
Denver 41
Naples 41
Orem 41
Helsinki 38
Phoenix 38
Atlanta 36
Nanjing 36
Munich 33
Chicago 31
Parma 31
Padova 30
Da Nang 28
Haiphong 28
Johannesburg 28
San Francisco 28
Buffalo 26
Lubumbashi 26
Turin 26
Westminster 26
São Paulo 25
Amsterdam 24
Bengaluru 23
Berlin 23
Abeokuta 22
Frankfurt am Main 22
Redondo Beach 22
Bern 21
London 21
Montreal 21
San Diego 20
Amman 19
Shanghai 19
Catania 17
Changsha 17
Rimini 17
Nuremberg 16
Piscataway 16
Toronto 16
Lappeenranta 15
Pisa 15
Sofia 15
Bangkok 14
Brussels 14
Guangzhou 14
Hyderabad 14
Jakarta 14
Redmond 14
Reggio Emilia 14
Vienna 14
Beerse 12
Falls Church 12
Modena 12
Padua 12
Saint Petersburg 12
Secaucus 11
Washington 11
Ardabil 10
Brooklyn 10
Des Moines 10
Jinan 10
Manchester 10
Nanchang 10
Pomigliano d'Arco 10
Poplar 10
Totale 6.816
Nome #
Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome 561
METODO E KIT PER LA DIAGNOSI DELLA SENSIBILITA’ AL GLUTINE NON ASSOCIATA ALLA CELIACHIA 437
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 368
Management of Irritable Bowel Syndrome With Diarrhea 353
5-oxoETE triggers nociception in constipation-predominant irritable bowel syndrome through MAS-related G protein–coupled receptor D 345
Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators 323
Consumption of 2 Green Kiwifruits Daily Improves Constipation and Abdominal Comfort - Results of an International Multicenter Randomized Controlled Trial 289
Collinsella aerofaciens as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome 284
Lactiplantibacillus plantarum (CECT7484 and CECT7485) and Pedioccoccus acidilactici (CECT7483) enhance actin cytoskeleton and CYP1A1 expression restoring epithelial permeability alterations induced by irritable bowel syndrome mediators 260
Serum zonulin and its diagnostic performance in non-coeliac gluten sensitivity 255
Advancements in drug development for diarrhea-predominant irritable bowel syndrome 251
A Probiotic Mixture of Lactobacillus rhamnosus LR 32, Bifidobacterium lactis BL 04, and Bifidobacterium longum BB 536 Counteracts the Increase in Permeability Induced by the Mucosal Mediators of Irritable Bowel Syndrome by Acting on Zonula Occludens 1 247
Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome 246
Pathophysiology of Diverticular Disease: From Diverticula Formation to Symptom Generation 243
New insights into irritable bowel syndrome pathophysiological mechanisms: contribution of epigenetics 238
Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier 232
Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial 227
Molecular Mechanisms Underlying Loss of Vascular and Epithelial Integrity in Irritable Bowel Syndrome 226
Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor beta2 211
The role of microbiota and its modulation in colonic diverticular disease 210
Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis 208
Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers 202
Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS 201
Diagnostic challenges of symptomatic uncomplicated diverticular disease 201
Post COVID-19 irritable bowel syndrome 199
Non-celiac gluten sensitivity in the context of functional gastrointestinal disorders 192
Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome 191
Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism 189
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 183
Pathophysiology and Clinical Management of Bile Acid Diarrhea 181
The Role of Microbiota in Upper Gastrointestinal Cancers 179
Nerve fiber overgrowth in patients with symptomatic diverticular disease 177
Cytochromes b561: ascorbate-mediated trans-membrane electron transport 176
Microbiota modulation in disorders of gut-brain interaction 169
Chronic constipation: from pathophysiology to management 169
Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases 168
Supernatants of irritable bowel syndrome mucosal biopsies impair human colonic smooth muscle contractility 167
Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. 165
Meta-analysis: Post-COVID-19 functional dyspepsia and irritable bowel syndrome 163
µ-opioid receptor, β-endorphin, and cannabinoid receptor-2 are increased in the colonic mucosa of irritable bowel syndrome patients. 150
Corrigendum: Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier (Front. Nutr., (2021), 8, (718356), 10.3389/fnut.2021.718356) 150
Treatment of diverticular disease with aminosalicylates: The evidence 149
Implications of SARS-CoV-2 infection for neurogastroenterology 146
Fecal short-chain fatty acids in non-constipated irritable bowel syndrome: a potential clinically relevant stratification factor based on catabotyping analysis 144
Recent advances in understanding non-celiac gluten sensitivity 142
Antibiotic use during gastrointestinal infections increases the risk of developing irritable bowel syndrome: a Systematic Review and Meta-Analysis 138
Protease-activated receptor 1 is implicated in irritable bowel syndrome mediators-induced signaling to thoracic human sensory neurons 132
Gut microbiota signatures and modulation in irritable bowel syndrome 127
Pre- and probiotic overview 121
AIR12, a b-type cytochrome of the plasma membrane of Arabidopsis thaliana is a negative regulator of resistance against Botrytis cinerea 121
Impact of the Trophic Effects of the Secretome from a Multistrain Probiotic Preparation on the Intestinal Epithelia 107
Functional Foods and Nutraceuticals in Irritable Bowel Syndrome 105
Long-Term Impact of COVID-19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities 103
null 101
Role of inflammation in pediatric irritable bowel syndrome 96
Digestive symptoms in daily life of chronic adrenal insufficiency patients are similar to irritable bowel syndrome symptoms 96
Italian nationwide survey of pharmacologic treatments in diverticular disease: Results from the REMAD registry 95
Letter: Post-COVID-19 disorders of gut–brain interaction (DGBI)—just post-infectious or a multifaceted entity? Authors' reply 91
Multistrain Probiotics Plus Vitamin D Improve Gut Barrier Function and Gut Microbiota Composition in Irritable Bowel Syndrome Without Constipation: Results from a Double-Blind, Randomized, Placebo-Controlled Trial 82
null 81
Psychological and Clinical Factors Mediate Post-COVID-19 Irritable Bowel Syndrome 72
Letter: Post-COVID-19 functional dyspepsia and irritable bowel syndrome—Authors' reply 72
Therapeutic Role of Probiotics for the Treatment of Dyspepsia: A Review of the Literature 60
Totale 11.967
Categoria #
all - tutte 31.744
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.744


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022751 0 0 0 36 75 47 44 44 53 24 325 103
2022/20231.015 75 209 71 75 77 80 34 88 154 24 66 62
2023/2024579 21 59 39 56 70 66 22 29 30 86 64 37
2024/20252.048 107 253 183 196 265 100 144 126 75 138 158 303
2025/20264.395 303 374 326 330 348 214 629 185 819 303 234 330
2026/20271.492 402 408 450 232 0 0 0 0 0 0 0 0
Totale 11.967